Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies

OBJECTIVE: To expand on available information on the efficacy of oral lasmiditan for the acute treatment of migraine with particular focus on the timing of the effect and on its impact on migraine‐associated symptoms. BACKGROUND: Lasmiditan is a novel selective 5‐hydroxytryptamine 1F receptor agonis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashina, Messoud, Vasudeva, Raghavendra, Jin, Leah, Lombard, Louise, Gray, Elizabeth, Doty, Erin G., Yunes‐Medina, Laura, Kinchen, Kraig S., Tassorelli, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899640/
https://www.ncbi.nlm.nih.gov/pubmed/31529622
http://dx.doi.org/10.1111/head.13636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899640/
https://www.ncbi.nlm.nih.gov/pubmed/31529622
http://dx.doi.org/10.1111/head.13636

Ejemplares similares